CDC/IDSA COVID-19 Clinician Call: CDC Update on Variants; Practical Strategies for SARS-CoV-2 Testing; and Testing in Long-Term Care Settings

To Download a copy of the presentation click here.

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.

Moderator:

Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

Update on Variants

Vivien G. Dugan, PhD
Lead, Strain Surveillance and Emerging Variant Team
Laboratory and Testing Task Force
COVID-19 Emergency Response
Centers for Disease Control and Prevention

Scenario-Based Guidance for SARS-CoV-2 Testing in Symptomatic & Asymptomatic Patients

Francesca Lee, MD
Clinical Microbiology Laboratory Director
Associate Professor, Pathology & Internal Medicine
University of Texas Southwestern
Romney M. Humphries, PhD
Clinical Microbiology Laboratory Director
Professor of Pathology, Microbiology and Immunology
Vanderbilt University Medical Center

SARS-CoV-2 Testing in Long-Term Care Settings

Sujan Reddy, MD, MSc
Medical Director, Prevention Epicenters Program
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention